Award

1785-S - Raw material for mRNA vaccine development

CENTRE FOR PROCESS INNOVATION LIMITED

This public procurement record has 1 release in its history.

Award

08 Jul 2020 at 09:54

Award Notice
Summary of the contracting process

The Centre for Process Innovation Limited (CPI) is conducting a procurement process for the provision of raw materials necessary for mRNA vaccine development. Officially titled "1785-S - Raw material for mRNA vaccine development," this tender falls under the pharmaceutical products category and is based in the North East of England. The procurement process has reached the award stage, with a contract value of £763,000 awarded to Touchlight Genetics Ltd. The contract commenced on 19th June 2020 and is set to conclude on 18th December 2020. The procurement method used is a limited, negotiated procedure without prior publication, in accordance with public procurement regulations.

This tender presents a significant opportunity for businesses involved in pharmaceutical manufacturing and biotechnology, particularly those capable of supplying DNA templates for vaccine development. Firms that possess the necessary technical expertise and are experienced in negotiating Material Transfer Agreements (MTAs) would be well-positioned to compete in this space. Given the urgency and unique requirements of the COVID-19 vaccine project, businesses offering scalable and validated manufacturing processes for DNA production are likely to find considerable opportunity for growth through involvement in such critical and high-value contracts.

Find more tenders on our Open Data Platform.
How relevant is this notice?

D3 Tenders Premium

Win More Public Sector Contracts

AI-powered tender discovery, pipeline management, and market intelligence — everything you need to grow your public sector business.

Start Free Trial Book a Demo
All Features Pricing

Notice Information

Notice Title

1785-S - Raw material for mRNA vaccine development

Notice Description

CPI require a number of enzymes to use as part of its response to COVID-19 vaccine project. The Public Contract Regulations 2015 state in regulation 32.2) The negotiated procedure without prior publication may be used for public works contracts, public supply contracts and public service contracts in any of the following cases:- (ii)competition is absent for technical reasons Raw material for mRNA vaccine development/manufacture of a COVID 19 vaccine. This is a fast moving and time limited project. As a synthetically expressed mRNA vaccine, a DNA template is required for expression and manufacture. The DNA template design is the key IP and any transfer to 3rd party manufacturing sites needs to be protected with relevant MTA agreements. The DNA template can be manufactured in a couple of different ways, either using E. Coli to make conventional plasmid DNA template which then needs to be purified, or using a unique synthetic manufacturing route developed by the supplier to make a DNA template called "Doggy Bone DNA" dbDNA. The supplier already have an MTA with the research company and have manufactured dbDNA in stock and ready for dispatch, any other supplier will need to negotiate an MTA with the research company and then develop a manufacturing process before being able to manufacture a product for sale. This process will take several months and cause a significant delay to the process development activities at CPI. The manufacturing process is unique to the supplier, fully validated and scalable and is able to supply any quantity of DNA required. No final decision can be made at this moment about the final supplier of the DNA template for final full scale manufacture but the supplier is the only company who is able to supply DNA to support the current development activities.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-b5fd17-292d9540-141a-4cb6-ae6f-b8bec80f3b78
Publication Source
Contracts Finder
Latest Notice
https://www.contractsfinder.service.gov.uk/Notice/c3e4658e-4323-42de-b3e8-387a09d8b960
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
Award Notice
Procurement Type
Standard
Procurement Category
Goods
Procurement Method
Limited
Procurement Method Details
Negotiated procedure without prior publication (above threshold)
Tender Suitability
SME
Awardee Scale
SME

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£763,000 £500K-£1M
Lots Value
Not specified
Awards Value
£763,000 £500K-£1M
Contracts Value
Not specified

Notice Dates

Publication Date
8 Jul 20205 years ago
Submission Deadline
11 Jun 2020Expired
Future Notice Date
Not specified
Award Date
18 Jun 20205 years ago
Contract Period
18 Jun 2020 - 18 Dec 2020 6-12 months
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Not Specified
Awards Status
Active
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
CENTRE FOR PROCESS INNOVATION LIMITED
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
REDCAR
Postcode
TS10 4RF
Post Town
Cleveland
Country
England
Major Region (ITL 1)
TLC North East (England)
Basic Region (ITL 2)
TLC3 Tees Valley
Small Region (ITL 3)
TLC32 South Teesside
Delivery Location
TLC North East (England)
Local Authority
Redcar and Cleveland
Electoral Ward
Dormanstown
Westminster Constituency
Redcar

Supplier Information

Number of Suppliers
1
Supplier Name

TOUCHLIGHT GENETICS

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

Download

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts. 

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-b5fd17-292d9540-141a-4cb6-ae6f-b8bec80f3b78-2020-07-08T10:54:35+01:00",
    "date": "2020-07-08T10:54:35+01:00",
    "ocid": "ocds-b5fd17-292d9540-141a-4cb6-ae6f-b8bec80f3b78",
    "language": "en",
    "initiationType": "tender",
    "tender": {
        "id": "1785-S",
        "title": "1785-S - Raw material for mRNA vaccine development",
        "description": "CPI require a number of enzymes to use as part of its response to COVID-19 vaccine project. The Public Contract Regulations 2015 state in regulation 32.2) The negotiated procedure without prior publication may be used for public works contracts, public supply contracts and public service contracts in any of the following cases:- (ii)competition is absent for technical reasons Raw material for mRNA vaccine development/manufacture of a COVID 19 vaccine. This is a fast moving and time limited project. As a synthetically expressed mRNA vaccine, a DNA template is required for expression and manufacture. The DNA template design is the key IP and any transfer to 3rd party manufacturing sites needs to be protected with relevant MTA agreements. The DNA template can be manufactured in a couple of different ways, either using E. Coli to make conventional plasmid DNA template which then needs to be purified, or using a unique synthetic manufacturing route developed by the supplier to make a DNA template called \"Doggy Bone DNA\" dbDNA. The supplier already have an MTA with the research company and have manufactured dbDNA in stock and ready for dispatch, any other supplier will need to negotiate an MTA with the research company and then develop a manufacturing process before being able to manufacture a product for sale. This process will take several months and cause a significant delay to the process development activities at CPI. The manufacturing process is unique to the supplier, fully validated and scalable and is able to supply any quantity of DNA required. No final decision can be made at this moment about the final supplier of the DNA template for final full scale manufacture but the supplier is the only company who is able to supply DNA to support the current development activities.",
        "status": "complete",
        "classification": {
            "scheme": "CPV",
            "id": "33600000",
            "description": "Pharmaceutical products"
        },
        "items": [
            {
                "id": "1",
                "deliveryAddresses": [
                    {
                        "region": "North East",
                        "countryName": "United Kingdom"
                    }
                ]
            }
        ],
        "value": {
            "amount": 763000,
            "currency": "GBP"
        },
        "procurementMethod": "limited",
        "procurementMethodDetails": "Negotiated procedure without prior publication (above threshold)",
        "tenderPeriod": {
            "endDate": "2020-06-11T23:59:59+01:00"
        },
        "contractPeriod": {
            "startDate": "2020-06-19T00:00:00+01:00",
            "endDate": "2020-12-18T23:59:59Z"
        },
        "suitability": {
            "sme": true,
            "vcse": false
        },
        "mainProcurementCategory": "goods"
    },
    "parties": [
        {
            "id": "GB-SRS-sid4gov.cabinetoffice.gov.uk/au8q6EUc",
            "name": "CENTRE FOR PROCESS INNOVATION LIMITED",
            "identifier": {
                "legalName": "CENTRE FOR PROCESS INNOVATION LIMITED",
                "scheme": "GB-SRS",
                "id": "sid4gov.cabinetoffice.gov.uk/au8q6EUc"
            },
            "address": {
                "streetAddress": "Wilton",
                "locality": "REDCAR",
                "postalCode": "TS104RF",
                "countryName": "England"
            },
            "contactPoint": {
                "name": "CPI Procurement",
                "email": "e-tendering@uk-cpi.com",
                "telephone": "01740 625716"
            },
            "roles": [
                "buyer"
            ]
        },
        {
            "id": "GB-COH-06422158",
            "name": "Touchlight Genetics Ltd",
            "identifier": {
                "legalName": "Touchlight Genetics Ltd",
                "scheme": "GB-COH",
                "id": "06422158"
            },
            "address": {
                "streetAddress": "40 Queen Anne Street, London, London, W1G 9EL"
            },
            "details": {
                "scale": "sme",
                "vcse": false
            },
            "roles": [
                "supplier"
            ]
        }
    ],
    "buyer": {
        "id": "GB-SRS-sid4gov.cabinetoffice.gov.uk/au8q6EUc",
        "name": "CENTRE FOR PROCESS INNOVATION LIMITED"
    },
    "awards": [
        {
            "id": "ocds-b5fd17-292d9540-141a-4cb6-ae6f-b8bec80f3b78-1",
            "status": "active",
            "date": "2020-06-19T00:00:00+01:00",
            "datePublished": "2020-07-08T10:54:35+01:00",
            "value": {
                "amount": 763000,
                "currency": "GBP"
            },
            "suppliers": [
                {
                    "id": "GB-COH-06422158",
                    "name": "Touchlight Genetics Ltd"
                }
            ],
            "contractPeriod": {
                "startDate": "2020-06-19T00:00:00+01:00",
                "endDate": "2020-12-18T23:59:59Z"
            },
            "documents": [
                {
                    "id": "1",
                    "documentType": "awardNotice",
                    "description": "Awarded contract notice on Contracts Finder",
                    "url": "https://www.contractsfinder.service.gov.uk/Notice/c3e4658e-4323-42de-b3e8-387a09d8b960",
                    "datePublished": "2020-07-08T10:54:35+01:00",
                    "format": "text/html",
                    "language": "en"
                }
            ]
        }
    ]
}